Not yet recruiting
Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR
NCT07696182· Abbott Medical Devices· Source
Contact: Nadia Bouhdi
Not yet recruiting
Fetal Ovarian Cysts and IOTA Terminology for Perinatal Management
NCT07587580· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: ANTONIA CARLA TESTA, Professor
Not yet recruiting
Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models
NCT07732933· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Gabriele Sani
Not yet recruiting
Machine Learning Algorithms Incorporating Radiomic Ultrasound Features
NCT07793201· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Antonia Carla Testa, Professor
Not yet recruiting
HERCULES: Ultrasound-Based Liver Involvement Classification in Ovarian Cancer
NCT07808320· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Antonia Carla Testa
Not yet recruiting
SCARLET - Italian proSpeCtionAl obseRvationaL multicEntre Study on Treatment for recTal pT1 Cancer
NCT07695519· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Giuditta Chiloiro, MD, Phd
Active, not recruiting
Advancing Risk Stratification in Endometrial Cancer
NCT07746024· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Recruiting
RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases
NCT07491237· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Francesca Augusta Gabrielli, MD PhD
Active, not recruiting
Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)
NCT07471802· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Recruiting
Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives
NCT07316621· GLSMED Learning Health S.A.· Source
Contact: Francesca Profeta, MSc
Not yet recruiting
Multiparametric Ultrasound for the Noninvasive Diagnosis of Porto-sinusoidal Vascular Liver Disorder
NCT07492862· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Maria Assunta Zocco
Recruiting
A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy
NCT07595653· argenx· Source
Contact: Raffaele Iorio, MD
Not yet recruiting
Surgical Handling of Fertility-preserving Treatments for Cervical Adenocarcinomas
NCT07394413· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Prof. Nicolò Bizzarri Bizzarri, MD, PhD
Not yet recruiting
SCUBE Proteins in Polycystic Ovary Syndrome (IPSOS)
NCT07396402· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Rosanna Apa, MD, PhD
Recruiting
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
NCT07287982· Phase 2· argenx· Source
Contact: Eugenio Mercuri
Recruiting
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
NCT07090005· Nitinotes Surgical Ltd.· Source
Contact: Vincenzo Bove, MD, PhD
Recruiting
REal Word aPpLicAtion of Molecular Based Endometrial Cancer Classification
NCT07555665· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Camilla Nero, MD PhD
Not yet recruiting
Evaluation of Cardiac and Endothelial Function in Children and Adolescents Treated With Anthracycline
NCT07253077· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Antonio Ruggiero, MD
Active, not recruiting
Comfortage - AD Prevention Strategies
NCT06896201· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Recruiting
Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer
NCT07389265· Phase 3· University of Campania Luigi Vanvitelli· Source
Contact: Giampaolo Tortora (principal investigator)
Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
NCT07070232· Phase 1/2· BioNTech SE· Source
Recruiting
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
NCT07092670· Intergruppo Melanoma Italiano· Source
Contact: Ernesto Rossi
Recruiting
Feasibility and Safety of Targeting Neutral vs Liberal Fluid Balance in Traumatic Brain Injured Patients- LIMIT-TBI Trial
NCT07625995· Phase 2· Erasme University Hospital· Source
Contact: Anselmo Caricato, MD
Not yet recruiting
Ultrasound Training Program for Gynecologic Cancer Staging in Residents
NCT07028229· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Antonia Carla Testa
Not yet recruiting
Ultrasound and Histology in AEH and Early EEC Treated Conservatively
NCT07028242· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Antonia Carla Testa
Recruiting
High-frequency Ultrasound for Intraoperative Lymph Node Assessment in Gynecological Cancer: From Surgery to Radiomics
NCT06906705· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: ANTONIA CARLA TESTA, Professor
Active, not recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
NCT06872125· Phase 3· Stoke Therapeutics, Inc· Source
Recruiting
A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis
NCT07724990· Catholic University of the Sacred Heart· Source
Contact: Antonio Gasbarrini
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
NCT06824467· Phase 3· Merck Sharp & Dohme LLC· Source
Recruiting
Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
NCT06690840· Phase 2· European Institute of Oncology· Source
Contact: Alessandra Fabi, MD
Recruiting
Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.
NCT06865274· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Massimiliano Mirabella
Recruiting
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
NCT06733038· Phase 3· Gruppo Oncologico del Nord-Ovest· Source
Contact: Lisa Salvatore, MD
Recruiting
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
NCT06298565· argenx· Source
Contact: Raffaele Iorio, MD
Recruiting
Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario
NCT06836219· Consorzio Oncotech· Source
Contact: Claudia M Claudia Marchetti, MD
Recruiting
Early Diagnosis of High-grade Serous Epithelial Ovarian Cancer Through the Analysis of DNA Derived From Pap Test Smear.
NCT07556562· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: NERO CAMILLA, MD
Recruiting
First in Human Study to Assess Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus
NCT06451718· Recornea Srl· Source
Contact: Luigi Mosca, MD
Active, not recruiting
Non-invasive Tests for Non-alcoholic Steato-hepatitis
NCT07502755· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Recruiting
Multidimensional Omics Analysis in Malignant Pleural Mesothelioma
NCT07561190· Azienda USL Reggio Emilia - IRCCS· Source
Contact: Filippo Lococo, MD
Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT06112314· Phase 3· Immunocore Ltd· Source
Recruiting
Italian PheNotypes Obstructive Sleep Apnea Study
NCT06872242· Istituto Auxologico Italiano· Source
Contact: Valerio Brunetti
Recruiting
The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population
NCT07558889· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Francesco Fanfani, MD
Recruiting
SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS
NCT06071286· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source
Contact: Camilla Nero, PHD
Recruiting
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
NCT06299748· argenx· Source
Contact: Sabine Coppieters, MD
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453· Institut für Pharmakologie und Präventive Medizin· Source
Contact: Francesco Burzotta, Dr.
Active, not recruiting
A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT05776472· Swedish Orphan Biovitrum· Source
Active, not recruiting
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
NCT05876754· Phase 3· Servier Affaires Médicales· Source
Recruiting
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
NCT05601700· Phase 3· Ente Ospedaliero Ospedali Galliera· Source
Contact: Domenica Lorusso, Prof.
Active, not recruiting
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
NCT05531565· Phase 2/3· Biogen· Source
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
NCT05429632· Phase 3· Priothera SAS· Source
Contact: Simona Sica, MD
Active, not recruiting
Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
NCT05177835· Phase 2· Abivax S.A.· Source
Showing 50 of 59.